Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,891 | 1,936 | 26.07. | |
1,907 | 1,915 | 26.07. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.07. | Clariane Announces the Success of Its Share Capital Increase With Preferential Subscription Rights of Approximately €237 Million as Part of Its Plan to Strengthen Its Financial Structure | 381 | Business Wire | Regulatory News:
Not to be published, distributed or circulated directly or indirectly in the United States, Canada, Australia or Japan. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES... ► Artikel lesen | |
26.06. | Clariane Confirms the Disposal of Its Activity « Les Essentielles » | 1.047 | Business Wire | Regulatory News:
The Clariane group (CLARI, ISIN FR00 10 386 334) announces that it has finalized the disposal of its residence services activity "Les Essentielles" to Odalys, a subsidiary of the... ► Artikel lesen | |
13.06. | Clariane: Information on the Availability of a Second Amendment to the 2023 Universal Registration Document | 378 | Business Wire | Regulatory News:
Clariane (Paris:CLARI), Europe's leading community for care in times of vulnerability (the "Company"), announces that a second amendment (the "Second Amendment") to the 2023 Universal... ► Artikel lesen | |
13.06. | Clariane: Clariane Launches a Share Capital Increase With Preferential Subscription Rights of Approximately €237 Million as Part of the Group's Plan to Strengthen Its Financial Structure | 596 | Business Wire | Key transaction terms: Subscription price: €1.11 per new share Subscription ratio: 3 new shares for 2 existing shares Theoretical value of the preferential subscription right:... ► Artikel lesen | |
12.06. | Clariane Announces the Completion of the Reserved Capital Increase of Around €92.1 Million | 420 | Business Wire | Regulatory News:
Clariane (Paris:CLARI), Europe's leading community for care in times of vulnerability (the "Company") announces that the reserved capital increase of approximately 92.1 million... ► Artikel lesen | |
10.06. | Clariane: The General Meeting of 10 June 2024 Approves All the Resolutions Supported by the Board of Directors, Including the Reserved Capital Increase of Around 92.1 Million Euros for the Benefit of HLD Europe, Flat Footed and Leima Valeurs | 416 | Business Wire | Regulatory News:
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN. THIS COMMUNICATION IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OF AMERICA OR ANY... ► Artikel lesen | |
01.06. | Clariane: Information relating to the availability of a prospectus approved by the Autorité des marchés financiers under number 24-191 | 659 | Business Wire | Regulatory News:
NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN. THIS COMMUNICATION IS NOT AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OF AMERICA OR ANY... ► Artikel lesen | |
01.06. | Clariane: Information on the Availability of an Amendment to the 2023 Universal Registration Document | 685 | Business Wire | Regulatory News:
Clariane (Paris:CLARI) (CLARIA.PA ISIN FR0010386334), Europe's leading community for care in times of vulnerability (the "Company"), announces that an amendment (the "Amendment")... ► Artikel lesen | |
21.05. | Clariane shares hit over half-year high on new mid-term targets | 29 | Reuters | ||
21.05. | Clariane Presents Its Medium-term Plan 2023-2026 | 460 | Business Wire | A €1.5 billion refinancing plan to strengthen its financial structure well under way, including the execution of the capital increase to be approved by the Annual shareholder meeting on the 10th... ► Artikel lesen | |
17.05. | Clariane Announces Two Capital Increases Totalling C. €328 Million, to Strengthen Its Financial Structure With the Investment of a New Major Shareholder Alongside Credit Agricole Assurances: the Group HLD Europe | 529 | Business Wire | The group HLD Europe plans to enter the capital of Clariane with an investment representing a shareholding of 20%, through a reserved capital increase that will be submitted to the vote of the next... ► Artikel lesen | |
06.05. | CLARIANE: Implementation of the Plan to Strengthen Clariane's Financial Structure - Disposal of the Hospitalisation à Domicile (HAD) Activity in France | 508 | Business Wire |
Regulatory News:
Clariane (Paris:CLARI) (CLARIA.PA ISIN FR0010386334): the Group announces today that it has received a put option agreement from the Fondation Santé Service and has granted an... ► Artikel lesen | |
06.05. | CLARIANE: Information on the Availability of the 2023 Universal Registration Document | 315 | Business Wire | Regulatory News:
Clariane (Paris:CLARI), the leading European community for care in times of vulnerability, announces the release of its 2023 Universal Registration Document.
The 2023 Universal... ► Artikel lesen | |
06.05. | Clariane: Availability and consultation of the information relating to the Combined General Meeting to be held on 10 June 2024 | 293 | Business Wire | Regulatory News:
Clariane (CLARIA.PA ISIN FR0010386334) (Paris:CLARI) informs its shareholders that a Combined General Meeting (the "General Meeting") of the Company will take place on Monday 10... ► Artikel lesen | |
03.05. | CLARIANE: Renewal of the Revolving Credit Facility and Update on the Refinancing Plan | 416 | Business Wire | Regulatory News:
Clariane (Paris:CLARI) (CLARIA.PA ISIN FR0010386334) announced today that it has renewed the drawdown of its RCF (Revolving Credit Facility) for a period of 6 months (expiring... ► Artikel lesen | |
02.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 02.05.2024 | 748 | Xetra Newsboard | Das Instrument GZF FR0010208488 ENGIE S.A. INH. EO 1 EQUITY wird ex Kapitalmassnahme gehandelt am 02.05.2024 The instrument GZF FR0010208488 ENGIE S.A. INH. EO 1 EQUITY is traded ex capital adjustment... ► Artikel lesen | |
25.04. | Clariane: First Quarter 2024 Revenue | 585 | Business Wire | Solid business growth in the first quarter of 2024: revenue up 7.4% All regions and business segments contributing to growth Refinancing Plan well underway in the first quarter:
... ► Artikel lesen | |
04.04. | Clariane - Rumor of Disposal of the HAD Activity in France | 571 | Business Wire | Regulatory News:
Clariane (CLARIA.PA ISIN FR0010386334): in response to rumours reported in the press, the Company confirms that it is currently studying various targeted disposal options as part... ► Artikel lesen | |
26.03. | Clariane: The Combined General Meeting of Shareholders of 26 March 2024 Votes in Favour of All the Proposed Resolutions, in Particular Those Concerning the Capital Increase of 300 Million Euros | 652 | Business Wire | Regulatory News:
The Combined General Meeting of Clariane (Paris:CLARI) shareholders was held on 26 March 2024, chaired by Jean-Pierre Duprieu, Chairman of the Board of Directors, and attended... ► Artikel lesen | |
21.03. | Clariane's Employee Shareholders1 Are in Favour of the Resolutions Submitted to the Combined General Meeting of 26 March 2024 | 339 | Business Wire | Regulatory News:
The elected employee representatives of the Supervisory Boards of the Korus FCPE2 and the Korian Actionnariat FCPE, meeting on 12 March 2024, decided that they would vote in favour... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 31,860 | 0,00 % | Fresenius: Dank defensiver Qualitäten zum Outperformer | Die Aktie von Fresenius hat sich zuletzt als einer der Outperformer im DAX entpuppt. Charttechnisch sieht es jetzt spannend aus. Der Kurs steht direkt vor einer wichtigen Hürde und könnte mittelfristig... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,180 | -1,51 % | Kurs der FMC-Aktie verharrt auf Vortags-Niveau (52,8534 €) | Der Kurs der dem Anteilsschein von FMC kommt kaum von der Stelle. Die Aktie notiert aktuell bei 57,55 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich gegenwärtig... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,30 | +0,38 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers vor Quartalszahlen auf "Overweight" mit einem Kursziel von 72,90 Euro belassen. Seine Prognosen für Umsatz... ► Artikel lesen | |
CARL ZEISS MEDITEC | 61,70 | +1,98 % | RBC stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 85 Euro belassen. Bei den anstehenden Zahlen der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
ECKERT & ZIEGLER | 43,360 | +2,12 % | Eckert&Ziegler-Aktie leicht im Minus (43,00 €) | Im deutschen Wertpapierhandel liegt das Wertpapier von Eckert&Ziegler derzeit im Minus. Zuletzt zahlten Investoren für die Aktie 43,00 Euro. Ein Wertverlust in Höhe von 1,54 Euro müssen derzeit die... ► Artikel lesen | |
DRAEGERWERK | 48,300 | +0,21 % | DZ BANK stuft Draegerwerk auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Drägerwerk nach vorläufigen Zahlen für das erste Halbjahr von 51 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Alles... ► Artikel lesen | |
MEDTRONIC | 72,79 | +0,41 % | Cosmo-Zahlen im ersten Semester von Medtronic-Deal gestützt | Dublin - Das Spezialitätenpharma-Unternehmen Cosmo hat im ersten Semester 2024 dank der Zusammenarbeit mit dem US-Konzern Medtronic einen deutlichen Sprung bei Umsatz und Gewinn verzeichnet. Für das... ► Artikel lesen | |
INTUITIVE SURGICAL | 407,00 | +0,12 % | Better Buy: Abbott Laboratories vs. Intuitive Surgical | ||
TELADOC HEALTH | 8,562 | -0,83 % | Teladoc Health, Inc.: Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08 | PURCHASE, NY, July 08, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued inducement awards to two new employees.... ► Artikel lesen | |
GERRESHEIMER | 93,75 | +1,46 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer auf "Overweight" mit einem Kursziel von 121,80 Euro belassen. Dass der US-Branchenkollege West Pharma enttäuschende Quartalszahlen... ► Artikel lesen | |
UNITEDHEALTH | 525,20 | +0,08 % | Unitedhealth Aktie: Insiderverkäufe beeinflussen Marktbewertung | UnitedHealth Group, ein führendes Unternehmen im US-Gesundheitssektor, verzeichnet bedeutende Insiderverkäufe. Thomas Roos, Chief Accounting Officer, veräußerte kürzlich 2.851 Aktien, während Erin McSweeney... ► Artikel lesen | |
THERMO FISHER | 560,40 | +0,18 % | Thermo Fisher Scientific Lifts FY24 Earnings, Revenue Forecast After Q2 Earnings Beat Market | WASHINGTON (dpa-AFX) - Thermo Fisher Scientific (TMO), while reporting higher second-quarter earnings but weak sales, on Wednesday raised its fiscal 2024 outlook.For the full year, the company... ► Artikel lesen | |
STRATEC | 41,300 | -0,48 % | DEUTSCHE BANK RESEARCH stuft STRATEC BIOMEDICAL SYSTEMS AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Stratec vor Zahlen zum zweiten Quartal auf "Hold" mit einem Kursziel von 40 Euro belassen. Wie Analyst Jan Koch in einem... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
CAREMAX | 6,420 | +13,83 % | HotStocks USA: +27 % bei CareMax, - 28 % bei MaxLinear |